US ovarian cancer mortality rates declined from 1999 to 2020, but significant disparities remain across age, race, and geographic regions, highlighting the need for targeted public health efforts.

Genetic testing revealed that she was positive for BRCA1, a genetic mutation that increases one’s risk of breast and ovarian ...

Persistent pain in areas like the back, abdomen, head, bones, or chest could signal underlying health issues, including ...

As early-onset cancers rise, more people are faced with the question of how their treatment might affect their ability to ...

Background and objectives Brain metastases from ovarian cancer (BMFOC) are rare but associated with poor prognosis. This ...

The actual numbers of young people with cancer are still low relative to older people, but they're unlikely to stay low. The ...

The retired marathon runner’s daughter, Isla, was diagnosed with ovarian cancer when she was 13 after experiencing several symptoms, including stomach aches and loss of breath. Before the diagnosis, ...

Gynecologic clear cell cancers are aggressive malignant neoplasms with low response rates to chemotherapy. Among patients ...

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression, Cancer Cell, June 2025 DOI: (25)00253-3 ...

Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct biology makes it especially challenging to treat. While the origin of this ...

Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...